
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-05-21 10:10:22Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Krebs Biochemicals & Industries Ltd Locks at Lower Circuit With 4.02% Loss — Sellers Queue, No Buyers in Sight
2026-05-20 12:00:07At Rs 55.58, Krebs Biochemicals & Industries Ltd locked at its lower circuit of 4.02% on 20 May 2026, with sellers lined up but no buyers willing to absorb the supply. The 5% price band limited the daily loss, yet the unfilled sell orders highlight persistent selling pressure and a frozen price.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
07-Aug-2026 | Source : BSEThe Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026
Results
06-Aug-2026 | Source : BSEResults for the quarter ended 30602026
Board Meeting Outcome for Outcome Of BM
06-Aug-2026 | Source : BSEOutcome of BM
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19